Skip to main content
. Author manuscript; available in PMC: 2013 Feb 11.
Published in final edited form as: J Neuroendocrinol. 2012 Apr;24(4):629–641. doi: 10.1111/j.1365-2826.2011.02237.x

Fig. 2.

Fig. 2

Positive controls for vesicle associated membrane protein 2 (VAMP-2) antibody and technique. Hypothalamic sections (A–C) show vasopressin (VP) and the large dense-cored vesicle protein chromogranin A (CGA)+B co-localised (C). In anterior pituitary sections (D–I), luteinising hormone (LH) is co-localised with both CGA+B and VAMP-2, as shown in the overlay images (F, I), demonstrating that the tissue and technique is not responsible for the absence of oxytocin and vasopressin co-localisation with VAMP-2 in cell somata and dendrites shown in previous figure. Scale bars = 10 μm.